Publication Name	World Journal of Gastroenterology
Manuscript ID	91187
Country	Japan

Received	2023-12-24 05:12
Peer-Review Started	2023-12-24 05:12
To Make the First Decision
Return for Revision	2024-01-19 01:02
Revised	2024-01-24 01:06
Second Decision	2024-04-01 01:37
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2024-04-01 02:01
Articles in Press	2024-04-01 02:01
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-04-22 00:46
Publish the Manuscript Online	2024-04-26 08:53

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Drug-induced mucosal alterations observed during esophagogastroduodenoscopy
Manuscript Source	Invited Manuscript
All Author List	Masaya Iwamuro, Seiji Kawano and Motoyuki Otsuka
Funding Agency and Grant Number
Corresponding Author	Masaya Iwamuro, MD, PhD, Assistant Professor, Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-Ku, Okayama 700-8558, Japan. pr145h2k@okayama-u.ac.jp
Key Words	Diagnosis; Esophagogastroduodenoscopy; Non-neoplastic lesions; Esophageal lesions; Gastric lesions; Duodenal lesions
Core Tip	Various lesions associated with medication use are detected during esophagogastroduodenoscopy, including pill-induced esophagitis, desquamative esophagitis, deteriorating gastroesophageal reflux, chemotherapy-induced esophagitis, proton pump inhibitor-induced gastric mucosal changes, medication-induced gastric erosions and ulcers, pseudomelanosis of the stomach, olmesartan-related gastric mucosal inflammation, lanthanum deposition in the stomach, zinc acetate hydrate tablet-induced gastric lesions, immune-related adverse event (irAE) gastritis, olmesartan-associated sprue-like enteropathy, duodenal pseudomelanosis, and lanthanum deposition. Endoscopists must diagnose these mucosal alterations by acquiring pertinent knowledge regarding medication-induced lesions, concomitant with inquiries concerning patient medication history.
Publish Date	2024-04-26 08:53
Citation	Iwamuro M, Kawano S, Otsuka M. Drug-induced mucosal alterations observed during esophagogastroduodenoscopy. World J Gastroenterol 2024; 30(16): 2220-2232
URL	https://www.wjgnet.com/1007-9327/full/v30/i16/2220.htm
DOI	https://dx.doi.org/10.3748/wjg.v30.i16.2220

Full Article (PDF)	WJG-30-2220-with-cover.pdf
Manuscript File	91187_Auto_Edited-YJP.docx
Answering Reviewers	91187-Answering reviewers.pdf
Audio Core Tip	91187-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	91187-Conflict-of-interest statement.pdf
Copyright License Agreement	91187-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	91187-Language certificate.pdf
Peer-review Report	91187-Peer-review(s).pdf
Scientific Misconduct Check	91187-Bing-Wang JJ-2.png
Scientific Editor Work List	91187-Scientific editor work list.pdf